Page 20 - Astrazeneca

AstraZeneca to test combining Covid-19 vaccine with Russian shot

Trials to start by the end of the year

Kiran Mazumdar-Shaw: Will take Covid vaccine; confident on safety, efficacy

Bharat Biotech, Serum Institute of India and Pfizer have applied to the Drugs Controller General of India seeking emergency use authorisation for their Covid-19 vaccine candidates

AstraZeneca's Covid-19 vaccine 70.4% effective at preventing the infection

AstraZeneca's Covid-19 vaccine is safe and effective at preventing symptomatic infection and it protects against severe disease and hospitalisation, a study concluded

US Astra Covid-19 vaccine trial will tell how well it works: Top scientist

A top US scientist overseeing Covid-19 vaccine trials expects a large US study to determine how effective AstraZeneca's experimental inoculation is

Decoded: What emergency use authorisation of Covid vaccine means for us

After the Indian arm of US pharmaceutical giant Pfizer, the Serum Institute of India has applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation

AstraZeneca, Qure.ai to bring AI solutions to detect lung cancer

The partnership aims to harness and scale-up the use of this technology to improve early-stage detection of lung cancer in the markets involved, to reduce mortality rates and improve patient outcomes.

India weighing quick emergency review of Pfizer, AstraZeneca vaccines

Serum Institute is making AstraZeneca's Covid-19 vaccine in India and has applied for emergency use authorisation.

Fortune or foresight? AstraZeneca, Oxford stories clash on Covid-19 vaccine

The discrepancy, reported for the first time by Reuters, centres on the regimen administered to a smaller group of volunteers in the late-stage trials, of half a dose followed by a full dose

Brazil to get 15 mn doses of Oxford-AstraZeneca Covid-19 vaccine in Jan-Feb

The first batch of 15 million doses of Oxford University and AstraZeneca's coronavirus vaccine will be shipped to Brazil in January and February, Health Minister Eduardo Pazuello said

AstraZeneca data, NovaVax delay spur Moderna Covid vaccine demand, says CEO

He also said that the higher efficacy rate "was in people younger than 55 years old."

AstraZeneca partner sticks with 2 full dose regimen in India Covid trials

The British drugmaker has said its COVID-19 vaccine could be up to 90% effective if administered as a half dose followed by a full dose

AstraZeneca sells cholesterol drug rights to Grünenthal for $320 million

AstraZeneca aims to streaming its businesses to focus on its cancer portfolio.

Airlines face 'mission of the century' in shipping coronavirus vaccines

United Airlines Holdings Inc. has begun flights to ready Pfizer's vaccine for distribution if it receives regulatory approval, said a person familiar with the matter

Inform people about vaccine in simple language, PM tells manufacturers

Serum Institute in Pune will undertake mass production of Covishield vaccine developed by Oxford-Astra Zeneca

Who will get Covid vaccine first? Serum CEO on distribution, pricing & Modi

Oxford vaccine: Serum to apply for emergency-use authorisation in 2 weeks

Serum Institute CEO Adar Poonawalla makes the announcement after a meeting with PM Narendra Modi, who was visiting key vaccine sites in India

Volunteer for Oxford's Covid-19 vaccine seeks Rs 5 crore compensation

Vaccine 'Covishield' is being manufactured by Pune-based Serum Institute of India

India Coronavirus Dispatch: What does '90% efficacy' for a vaccine mean?

Students aspiring to study abroad may face tougher competition in 2021, AstraZeneca's manufacturing error casts doubt over its potential, and other news relevant to India's fight against the pandemic

Suspected North Korean hackers targeted vaccine maker AstraZeneca: Report

The hackers posed as recruiters on networking site LinkedIn and WhatsApp to approach AstraZeneca staff with fake job offers

Covid updates on vaccine, lockdown chances and PM's Serum institute visit

Russia's sovereign wealth fund and Indian pharmaceutical company Hetero have agreed to produce over 100 million doses per year of Russia's Covid vaccine Sputnik V, in India